China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China · Delayed Price · Currency is CNY 27.69
-0.49 (-1.74%)
Apr 9, 2026, 3:04 PM CST
SHE:000999 Revenue
In the year 2025, China Resources Sanjiu Medical & Pharmaceutical had annual revenue of 31.60B CNY with 14.43% growth. China Resources Sanjiu Medical & Pharmaceutical had revenue of 9.62B in the quarter ending December 31, 2025, with 22.09% growth.
Revenue
31.60B
Revenue Growth
+14.43%
P/S Ratio
1.46
Revenue / Employee
1.04M
Employees
30,304
Market Cap
46.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.60B | 3.99B | 14.43% |
| Dec 31, 2024 | 27.62B | 2.88B | 11.63% |
| Dec 31, 2023 | 24.74B | 6.66B | 36.83% |
| Jan 1, 2023 | 18.08B | 2.54B | 16.31% |
| Jan 1, 2022 | 15.54B | 1.91B | 13.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| Humanwell Healthcare (Group) | 23.96B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Livzon Pharmaceutical Group | 12.02B |
| Dong-E-E-Jiao | 6.70B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |